Key Quantitative Figures

  • Net Loss for FY 2025-26: ₹2.10 lakhs (Previous year: ₹4.30 lakhs loss)
  • Revenue from Operations: Nil for both FY 2025-26 and FY 2024-25
  • Employee Benefit Expenses: ₹0.95 lakhs (Previous year: Nil)
  • Other Expenses: ₹1.15 lakhs (Previous year: ₹4.30 lakhs)
  • Paid-up Capital: ₹3.24 crores (32,40,000 equity shares of ₹10 each)
  • Authorized Capital: ₹3.50 crores
  • Cash and Cash Equivalents: ₹8.05 lakhs
  • Loans and Advances: ₹176.50 lakhs
  • Current Liabilities: ₹26.76 lakhs

Dates of Action

  • AGM Date: Friday, October 30, 2026 at 03:00 PM IST
  • Cut-off Date for E-voting: Friday, October 23, 2026
  • Remote E-voting Period: Tuesday, 27th October 2026 (09:00 AM) to Thursday, 29th October 2026 (05:00 PM)
  • Book Closure: Saturday, 24th October 2026 to Friday, 30th October 2026 (both days inclusive)
  • SAT Order Date: 17th March 2026 (setting aside compulsory delisting)
  • Name Change Approval: 12th June 2026 (from KD Leisures to Vedic Ayurveda)

Parties Involved

  • Stock Exchanges: BSE Limited, Calcutta Stock Exchange
  • Registrars & Transfer Agents: Purva Sharegistry (India) Limited
  • Statutory Auditors: M/s GAV & Associates, Chartered Accountants
  • Secretarial Auditor: M/s Vaibhav Sharma & Associates
  • Internal Auditor: M/s Goyal Nagpal & Co., Chartered Accountants (appointed w.e.f. 07.10.2026)
  • Bankers: ICICI Bank
  • Scrutinizer: M/s Amit Saxena & Associates

Business Resolutions

Ordinary Business:

1. Adoption of Audited Financial Statements for FY ended 31st March 2026

2. Re-appointment of Ms. Deepika Awasthi (DIN: 08624842) as Director retiring by rotation

Special Business:

3. Change in designation of Ms. Deepika Awasthi from Executive Director to Managing Director for 5 years from 29th October 2026

4. Regularization of Mr. Atul Chauhan (DIN: 03578401) as Independent Director for 5 years from 07th October 2026

5. Note revised certificate from Practicing Chartered Accountant regarding compliance with Regulation 45(1) for name change

6. Approval for creating charge on assets up to ₹100 crores under Section 180(1)(a)

7. Approval for borrowing funds up to ₹100 crores under Section 180(1)(c)

8. Approval for giving loans/guarantees up to ₹100 crores to interested parties under Section 185

9. Approval for loans/guarantees/investments up to ₹100 crores under Section 186

Financial and Operational Impact

  • No operational revenue generated during FY 2025-26
  • Strategic diversification into Ayurveda, herbal products, healthcare approved post-year end (22nd May 2026 EGM)
  • Trading suspension continues since 12th June 2023 due to non-compliance with listing requirements
  • Compulsory delisting order from BSE dated 22nd August 2024 set aside by SAT order dated 17th March 2026
  • Application submitted to BSE on 6th April 2026 for revocation of trading suspension
  • Income Tax Returns not filed for assessment years 2021-22 onwards (as per auditor's report)

Capital Structure Impact

  • No change in share capital during the year
  • No bonus shares, buybacks, or ESOPs issued
  • No dividend recommended due to losses

Management Changes

  • Appointments during FY 2025-26:
  • Ms. Deepika Awasthi as Executive Director (02.02.2026)
  • Ms. Kanchan Yadav as Independent Director (17.03.2026)
  • Ms. Anubha Kumari Sinha as Non-Executive Director (17.02.2026)
  • Ms. Jyoti as Company Secretary (11.06.2026)
  • Mr. Shekhar Chandrakant More as CFO (07.10.2026)
  • Resignations during FY 2025-26:
  • Mr. Parminder Singh (Director, 02.02.2026)
  • Mr. Dileep Kumar (Director, 17.02.2026)
  • Mr. Mandeep Singh Thukral as CFO (10.04.2026)
  • Ms. Anjali as Company Secretary (30.04.2026)

Auditor Qualifications

Statutory Auditors issued qualified opinion noting:

1. Confirmations regarding closing balances of loans and advances not made available

2. Company has not filed Income Tax Returns from assessment year 2021-22 onwards

Other Material Information

  • Registered Office changed during year from Mumbai to Unit No. 1109, 11th Floor, Lotus Link Square, D.N. Nagar, New Link Road, Andheri (West), Mumbai - 400053
  • Corporate Office: 117/N/328A Kakadeo, Raniganj, Naveen Nagar, Kanpur Nagar UP-208025